MediThinkQ's 'Scope Eye' Selected as a Next-Generation World-Class Product by 2025

MediThinQ (CEO Seungjun Lim), a medical XR·3D visual solution specialist, announced that its flagship product SCOPEYE was selected as the '2025 Next-Generation World Class Product' hosted by the Ministry of Trade, Industry and Energy and the Korea Trade-Investment Promotion Agency (KOTRA).

ScopeEye is a solution that utilizes "Eyes Up" 3D display technology, which displays high-quality medical images in real time before the medical team's eyes. Its key feature is its ability to enhance surgical accuracy and efficiency. It integrates with existing medical imaging equipment without the need for separate software installation and is designed to allow medical staff to focus on the procedure in a stable position. It also boasts innovative features in various fields, including wireless 3D visualization technology, Air Writing-based collaboration capabilities, and compatibility with various surgical environments.

MediThinkQ has established a growth foundation in the US and European markets through exclusive contracts with global healthcare companies, and in May of this year, it entered the Chinese market in earnest by signing an exclusive supply contract with Sinopharm, a Chinese medical device group.

Meanwhile, MediThinkQ is unveiling its main solutions, including ScopeEye and 3D Digital Exoscope SHIYA 20, at the medical device exhibition MEDICA 2025 held in Düsseldorf, Germany.

Lim Seung-jun, CEO of MediThinkQ, said, “This is an official recognition of ScopeEye’s technological prowess and global expansion potential,” and added, “We will continue to innovate XR and 3D display technologies to solve problems in the medical field.”


  • See more related articles